Vince Biemans

12PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AllergySocial epidemiologyHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 18, 2022
Favourable Tolerability and Drug Survival of Tioguanine Versus Methotrexate After Failure of Conventional Thiopurines in Crohn's Disease.

E H J Savelkoul, M H J Maas, A R Bourgonje

|Apr 28, 2021
Ustekinuma b for Crohn's Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, a Nationwide Prospective Observational Cohort Study.

Tessa Straatmijer, Vince B C Biemans, Frank Hoentjen

|Sep 09, 2020
Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab- and ustekinumab-treated patients with inflammatory bowel disease-a prospective multicentre cohort study.

Vera E R Asscher, Vince B C Biemans, Marieke J Pierik

|May 23, 2020
Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn's disease patients with prior failure to anti-TNF treatment.

Vince B C Biemans, C Janneke van der Woude, Gerard Dijkstra

|May 16, 2020
Effectiveness of ustekinumab dose escalation in Crohn's disease patients with insufficient response to standard-dose subcutaneous maintenance therapy.

Uri Kopylov, Jurij Hanzel, Claire Liefferinckx

|Apr 28, 2020
A comparative analysis of tioguanine versus low-dose thiopurines combined with allopurinol in inflammatory bowel disease patients.

Vince B C Biemans, Edo Savelkoul, Ruben Y Gabriëls

Pageof 2

Frequent Collaborators

2 joint publications

Vera E R Asscher

2 joint publications

P W Jeroen Maljaars

2 joint publications

Tessa Straatmijer

1 joint publications

E H J Savelkoul